Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
This is a multi-centre, open-label, randomized, parallel trial to compare the effect of
Exenatide versus Biphasic insulin Aspart 30 on glucose variability and inflammatory markers
in type 2 diabetes mellitus (T2DM) patients inadequately controlled with metformin
monotherapy.
Phase:
Phase 4
Details
Lead Sponsor:
Xijing Hospital
Collaborators:
Air Force Military Medical University, China Chang An Hospital Chang'An Hospital First Affiliated Hospital Xi'an Jiaotong University Fourth Military Medical University Second Affiliated Hospital of Xi'an Jiaotong University Shaanxi Aerospace Hospital Shaanxi Provincial People's Hospital Xi'an Central Hospital Xi'an Gaoxin Hospital Xi’an Gaoxin Hospital